EUVIMEDEUVIMED entdecken
Crossref

Procyanidin B1 Purified from Cinnamomi Cortex Suppresses Hepatitis C Virus Replication

Shenwei Li, Eiichi N Kodama, Yuuki Inoue, Hideki Tani, Yoshiharu Matsuura, Jing Zhang, Takashi Tanaka, Toshio Hattori

Antiviral Chemistry and Chemotherapy · 2010-08 · 20 (6) · 239-248

DOI: 10.3851/imp1597 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antiviral Chemistry and Chemotherapy, online erschienen am 01.08.2010. Verfasst von Shenwei Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Emerging Infectious Diseases, Department of Internal Medicine, Tohoku University, Sendai, Japan. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A combination of pegylated interferon and ribavirin is the current standard therapy for hepatitis C virus (HCV) infection, but this combination provides relatively low efficacy, especially in some patients with HCV genotype 1 infection; therefore, the development of novel therapeutic agents is required for further improvement in the treatment of chronic HCV infection.

Methods

HCV pseudotype and subgenomic replicon assays were used in this study. The interaction of compounds with HCV receptors was examined using flow cytometry. Intracellular RNA levels were determined by semi-quantitative reverse transcriptase PCR.

Results

Procyanidin B1 (PB1), a dimer of (−)-epicatechin and (+)-catechin, purified from Cinnamomi cortex, inhibits infection by vesicular stomatitis virus and HCV pseudotype virus in Huh-7 cells, with 50% effective concentrations of 29 and 15 μM, respectively. No inhibitory effects were observed in each component of PB1. We found that PB1 does not interfere with viral entry or receptor expression, but inhibits HCV RNA synthesis in a dose-dependent manner.

Conclusions

These results indicate that PB1 suppresses HCV RNA synthesis, possibly as a HCV RNA polymerase inhibitor. Our results might contribute towards the development of more effective inhibitors for HCV infection from natural plants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsBiflavonoidsCatechinCell Line, TumorCinnamomum zeylanicumDrugs, Chinese HerbalHepacivirusHepatitis CHepatitis C, ChronicHumansInterferon alpha-2Interferon-alphaProanthocyanidinsRNA, ViralRecombinant ProteinsRepliconRibavirinVirus InternalizationVirus Replication

Substanzen

Antiviral AgentsBiflavonoidsDrugs, Chinese HerbalInterferon alpha-2Interferon-alphaProanthocyanidinsRNA, ViralRecombinant Proteinscinnamomi cortexprocyanidin B1

Autor:innen und Institutionen

  • Division of Emerging Infectious Diseases, Department of Internal Medicine, Tohoku University, Sendai, Japan.

Zitieren

APA

Li, S., Kodama, E. N., Inoue, Y., Tani, H., Matsuura, Y., Zhang, J., Tanaka, T., & Hattori, T. (2010). Procyanidin B1 Purified from Cinnamomi Cortex Suppresses Hepatitis C Virus Replication. Antiviral Chemistry and Chemotherapy, 20(6), 239-248. https://doi.org/10.3851/imp1597

Vancouver

Li S, Kodama EN, Inoue Y, Tani H, Matsuura Y, Zhang J, et al. Procyanidin B1 Purified from Cinnamomi Cortex Suppresses Hepatitis C Virus Replication. Antiviral Chemistry and Chemotherapy. 2010;20(6):239-248. doi:10.3851/imp1597

BibTeX
@article{Li2010,
  author = {Li, Shenwei and Kodama, Eiichi N and Inoue, Yuuki and Tani, Hideki and Matsuura, Yoshiharu and Zhang, Jing and Tanaka, Takashi and Hattori, Toshio},
  title = {Procyanidin B1 Purified from Cinnamomi Cortex Suppresses Hepatitis C Virus Replication},
  journal = {Antiviral Chemistry and Chemotherapy},
  year = {2010},
  volume = {20},
  number = {6},
  pages = {239--248},
  doi = {10.3851/imp1597}
}
Kostenlos starten →